Nifedipine-induced gingival hyperplasia: a clinical and in vitro study.
about
Drugs and oral disorders.The role of drugs in the pathogenesis of gingival overgrowth. A collective review of current concepts.Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus.Treatment of drug-induced gingival enlargement: aesthetic and functional considerations.Oral and dental aspects of chronic renal failure.Medications: a risk factor for periodontal disease diagnosis and treatment.The management of drug-induced gingival overgrowth.Application of evidence-based dentistry: from research to clinical periodontal practice.Drugs, medications and periodontal disease.Drug-induced mouth disorders.Medications as risk factors for periodontal disease.Periodontal implications: medically compromised patients.Supragingival dental plaque in the etiology of oral diseases.Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine.Effect of periodontal treatment in renal transplant recipients.Amlodipine-induced gingival overgrowth: periodontal responses to stopping and restarting the drug.The gingival inflammatory infiltrate in cardiac patients treated with calcium antagonists.Effect of nifedipine on the expression of keratinocyte growth factor and its receptor in cocultured/monocultured fibroblasts and keratinocytes.Immunohistochemical analysis of Th1/Th2 cytokine profiles and androgen receptor expression in the pathogenesis of nifedipine-induced gingival overgrowth.The effect of angiotensin II on the proliferation of human gingival fibroblasts.Felodipine-influenced gingival enlargement in an uncontrolled type 2 diabetic patient.Diltiazem did not induce gingival overgrowth in rats. A clinical, histological and histometric analysis.Effect of Calcium Channel Blockers on Gingival Tissues in Hypertensive Patients in Lagos, Nigeria: A Pilot Study.The clinical effects of nifedipine on periodontal status.Prevalence of nifedipine-induced gingival hyperplasia.Effectiveness of periodontal therapy in patients with drug-induced gingival overgrowth. Long-term results.
P2860
Q33592359-A30BFF03-92D1-4CDB-B29C-C208F8999B86Q33768650-2D91728F-2C25-4639-BBD3-DC560FDDC1D8Q34076610-108AB88E-6D4A-42B3-B3F4-57F7913B4B0CQ34364977-24A3C837-CD4E-41D2-A1B1-78B79B8C52C1Q36050817-01F40715-AF3D-4A41-A1F2-3113C449BE3DQ36309242-36DCEC12-8FF0-4E7D-B40D-02DCCA1D405CQ36469413-C59C159C-71C0-49F9-A620-3242CACC08BBQ38002939-4CAA6E99-89FC-4A79-8FB9-97C077B249B2Q38262447-DE2AAF85-60A1-4A03-9A16-596A6347AFC3Q40480299-62519958-3794-4889-932D-B0F54C906406Q41204522-FCFA0F91-D91D-426E-AEBB-F0DE8457CBCAQ41444849-A4F24B25-53DC-45F4-B895-02D735623FCEQ41754826-C5A1E106-C660-4173-99E1-8A5FB85E7D56Q42661544-F619AB08-0381-4239-9F9A-187D413CFCDEQ42759487-DD4B085D-B719-4E63-B710-61F77319D002Q43694963-F8D44A05-038A-4A77-BBBF-F3582C17F8B6Q43784900-1A65FBA3-76A1-4A44-8DE3-242DB420A716Q43998997-2777A9A1-535E-4144-9D7D-B2BCCDC4E0CAQ44492772-33184288-19E6-4FF2-9807-1685CE364050Q45917093-582A3539-4BEC-4168-B340-04F43A037608Q46599834-B0C49B4F-E13C-4D05-AC82-D39BE2AA2F2AQ46820755-F42ECDCA-0107-4814-A779-450C315EECE5Q49167042-715E5C81-4A4E-42D7-B6F1-73DAA71D0147Q50898718-520CF305-CC70-4485-A8C2-92BA7C1E5DB2Q52337824-AB26D374-2E3E-48F4-827B-9A026F047E99Q52895133-E559C427-C0BA-479B-BD67-CBFAE2B5A1A8
P2860
Nifedipine-induced gingival hyperplasia: a clinical and in vitro study.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Nifedipine-induced gingival hyperplasia: a clinical and in vitro study.
@en
type
label
Nifedipine-induced gingival hyperplasia: a clinical and in vitro study.
@en
prefLabel
Nifedipine-induced gingival hyperplasia: a clinical and in vitro study.
@en
P2093
P2860
P356
P1476
Nifedipine-induced gingival hyperplasia: a clinical and in vitro study.
@en
P2093
Hamasaki A
Kasahara S
Nishikawa S
P2860
P356
10.1902/JOP.1991.62.1.30
P407
P577
1991-01-01T00:00:00Z